Related Experiment Video
Updated: Jan 30, 2026

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
DUSP1 Is a Potential Marker of Chronic Inflammation in Arabs with Cardiovascular Diseases
Abdelkrim Khadir1, Sina Kavalakatt1, Mohammed Dehbi2
1Research Division, Dasman Diabetes Institute, Kuwait.
Insights
Dual-specificity phosphatase 1 (DUSP1) may predict chronic inflammation and residual cardiovascular disease (CVD) risk. High-sensitivity C-reactive protein (hsCRP) association with CVD is linked to obesity, not inflammation.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Medicine
Background:
- Cardiovascular disease (CVD) poses ongoing risks despite conventional treatments, potentially linked to chronic inflammation.
- Epidemiological studies suggest a correlation between low-grade inflammatory markers and recurrent CVD events.
- This study investigates plasma dual-specificity phosphatase 1 (DUSP1) as a potential inflammatory marker in CVD patients.
Purpose of the Study:
- To assess plasma DUSP1 levels in CVD patients compared to controls.
- To compare DUSP1 with established markers: high-sensitivity C-reactive protein (hsCRP) and oxidized low-density lipoprotein (oxLDL).
- To explore the association of these markers with conventional CVD risk factors.
Main Methods:
- A cohort of 207 CVD patients and 70 controls in Kuwait was studied.
- Anthropometric and biochemical parameters were measured.
- Plasma levels of DUSP1, oxLDL, and hsCRP were quantified using enzyme-linked immunosorbent assay kits.
Main Results:
- Plasma DUSP1 and hsCRP levels were significantly higher in CVD cases, while oxLDL was lower.
- Multivariate analysis revealed independent associations of DUSP1 and hsCRP with CVD, indicating increased risk.
- DUSP1 associated with CVD independently of statin use and diabetes, whereas hsCRP correlated with obesity markers.
Conclusions:
- Circulating DUSP1 may serve as a predictor of chronic subclinical inflammation and residual CVD risk.
- The association between hsCRP and CVD appears primarily mediated by adiposity-related factors.
Background:
Cardiovascular disease (CVD) risks persist in patients despite the use of conventional treatments. This might be due to chronic inflammation as reflected in epidemiological studies associating circulating low-grade inflammatory markers with CVD recurrent events. Here, we explored this potential link by assessing plasma dual-specificity phosphatase 1 (DUSP1) levels and comparing them to high-sensitivity CRP (hsCRP) and oxidized low-density lipoprotein (oxLDL) levels and their associations to conventional CVD risk factors in confirmed CVD patients.
Methods:
Human adults with reported CVD (n = 207) and controls (n = 70) living in Kuwait were used in this study. Anthropometric and classical biochemical parameters were determined. Plasma levels of DUSP1, oxLDL, and hsCRP were measured using human enzyme-linked immunosorbent assay kits.
Results:
DUSP1 and hsCRP plasma levels and their least square means were higher in CVD cases, while oxLDL plasma levels were lower (p < 0.05). Multivariate logistic regression analysis showed that DUSP1 and hsCRP are independently associated with CVD in the studied population, as reflected by 2-fold and 1.5-fold increased risks with increased levels of DUSP1 and hsCRP, respectively. In our study, DUSP1 levels were found to be associated with CVD despite statin treatment and diabetes status (p < 0.05), whereas hsCRP mainly correlated with obesity markers.
Conclusions:
Circulating DUSP1 might be a predictor of chronic subclinical inflammation and residual risk in CVD patients, whereas our data suggest that the association between hsCRP and CVD is largely accounted for adiposity risk factors.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Inflammation
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

